NCT05604118View on ClinicalTrials.gov

Platelet Enzymatically Oxidized Phospholipids (eoxPL) Characterisation in a Healthy Cohort on and Off Aspirin

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 1, 2016

Primary Completion Date

August 1, 2018

Study Completion Date

June 1, 2022

Conditions

Platelet Dysfunction Due to Aspirin

Interventions

DRUG

Aspirin

1 week of aspirin supplementation prior to sampling

Trial Locations (1)

CF144XN

Sir Geraint Evans Cardiovascular Research Building, Cardiff

All Listed Sponsors

lead

Cardiff University

OTHER

NCT05604118 - Platelet Enzymatically Oxidized Phospholipids (eoxPL) Characterisation in a Healthy Cohort on and Off Aspirin | Biotech Hunter | Biotech Hunter